Stijn van Rompay
Founder chez HYLORIS PHARMACEUTICALS SA
Fortune : 95 M $ au 31/03/2024
Profil
Stijn van Rompay is the founder.
He founded Uteron Pharma SA in 2010 as the General Manager and Hyloris Pharmaceuticals SA in 2012 as the Chief Executive Officer & Executive Director.
Mr. van Rompay is also the founder of Alter Pharma Group NV.
Mr. van Rompay's current job(s) include being the Director at ImCyse SA since 2012, the Managing Director & Director at EXO Biologics SA since 2019, a Non-Executive Director at Coalesce Product Development Ltd., and the Managing Director & Director at Hyloris Developments SA since 2020.
Mr. van Rompay's former job includes being the Chief Financial Officer at Docpharma NV.
Mr. van Rompay's education history includes being a graduate from the University of Antwerp.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
HYLORIS PHARMACEUTICALS SA
27,42% | 31/12/2022 | 7 676 400 ( 27,42% ) | 95 M $ | 31/03/2024 |
Postes actifs de Stijn van Rompay
Sociétés | Poste | Début |
---|---|---|
HYLORIS PHARMACEUTICALS SA | Founder | 01/01/2012 |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Director/Board Member | 01/01/2012 |
EXO Biologics SA
EXO Biologics SA BiotechnologyHealth Technology EXO Biologics SA operates as a Belgian biotechnology company. The company is based in Liege, Belgium. The company was founded in 2019. Hugues Wallemacq has been the CEO of the company since 2021. | Director/Board Member | 29/08/2019 |
Coalesce Product Development Ltd.
Coalesce Product Development Ltd. Medical SpecialtiesHealth Technology Part of Novartis AG, Coalesce Product Development Ltd. is a British company that develops inhalation devices. The private company is based in Cambridge, UK. The company was founded in 2009 by Dave Ahern, who has been the CEO since 2009. Coalesce Product Development was acquired by Sandoz AG on March 14, 2022. | Director/Board Member | - |
Hyloris Developments SA
Hyloris Developments SA Pharmaceuticals: MajorHealth Technology Hyloris Developments SA is a Belgian pharmaceutical company that manufactures and sells pharmaceutical products. The private company is based in Liege, Belgium. The company was founded in 2013. The CEO is Stijn van Rompay. | Chief Executive Officer | 20/04/2020 |
Anciens postes connus de Stijn van Rompay
Sociétés | Poste | Fin |
---|---|---|
Uteron Pharma SA
Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Uteron Pharma SA is engaged in the research and development of controlled release devices. The firms products Levosert and Diafert provide pharmaceutical solutions for women's health. The company was founded by Stijn van Rompay in 2010 and is headquartered in Grâce-Hollogne, Belgium. | Chief Executive Officer | 01/08/2015 |
Alter Pharma Group NV
Alter Pharma Group NV Pharmaceuticals: MajorHealth Technology Alter Pharma Group NV manufactures and distributes pharmaceutical products. The company was founded in 2006 and is headquartered in Anderlecht, Belgium. | Founder | - |
Docpharma NV
Docpharma NV Pharmaceuticals: MajorHealth Technology Docpharma NV provides generic drugs. These drugs are used to treat infections, hypertension, allergies, bronchial and asthmatic problems, gastric and vomiting discomforts, pain and depression. It was founded by Leon Van Rompay in 1999 and is headquartered in Heverlee, Belgium. | Chief Executive Officer | - |
Formation de Stijn van Rompay
University of Antwerp | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
HYLORIS PHARMACEUTICALS SA | Health Technology |
Entreprise privées | 7 |
---|---|
Docpharma NV
Docpharma NV Pharmaceuticals: MajorHealth Technology Docpharma NV provides generic drugs. These drugs are used to treat infections, hypertension, allergies, bronchial and asthmatic problems, gastric and vomiting discomforts, pain and depression. It was founded by Leon Van Rompay in 1999 and is headquartered in Heverlee, Belgium. | Health Technology |
Uteron Pharma SA
Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Uteron Pharma SA is engaged in the research and development of controlled release devices. The firms products Levosert and Diafert provide pharmaceutical solutions for women's health. The company was founded by Stijn van Rompay in 2010 and is headquartered in Grâce-Hollogne, Belgium. | Electronic Technology |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Health Technology |
Alter Pharma Group NV
Alter Pharma Group NV Pharmaceuticals: MajorHealth Technology Alter Pharma Group NV manufactures and distributes pharmaceutical products. The company was founded in 2006 and is headquartered in Anderlecht, Belgium. | Health Technology |
EXO Biologics SA
EXO Biologics SA BiotechnologyHealth Technology EXO Biologics SA operates as a Belgian biotechnology company. The company is based in Liege, Belgium. The company was founded in 2019. Hugues Wallemacq has been the CEO of the company since 2021. | Health Technology |
Coalesce Product Development Ltd.
Coalesce Product Development Ltd. Medical SpecialtiesHealth Technology Part of Novartis AG, Coalesce Product Development Ltd. is a British company that develops inhalation devices. The private company is based in Cambridge, UK. The company was founded in 2009 by Dave Ahern, who has been the CEO since 2009. Coalesce Product Development was acquired by Sandoz AG on March 14, 2022. | Health Technology |
Hyloris Developments SA
Hyloris Developments SA Pharmaceuticals: MajorHealth Technology Hyloris Developments SA is a Belgian pharmaceutical company that manufactures and sells pharmaceutical products. The private company is based in Liege, Belgium. The company was founded in 2013. The CEO is Stijn van Rompay. | Health Technology |